Editorial: Cutaneous B-Cell Lymphomas
| dc.contributor.author | Alaibac, Mauro | |
| dc.contributor.author | Seckin, Deniz | |
| dc.contributor.author | Quaglino, Pietro | |
| dc.contributor.pubmedID | 33363042 | en_US |
| dc.date.accessioned | 2021-03-25T11:08:56Z | |
| dc.date.available | 2021-03-25T11:08:56Z | |
| dc.date.issued | 2020 | |
| dc.identifier.issn | 2234-943X | en_US |
| dc.identifier.scopus | 2-s2.0-85098071143 | en_US |
| dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756111/pdf/fonc-10-619709.pdf | |
| dc.identifier.uri | http://hdl.handle.net/11727/5622 | |
| dc.identifier.volume | 10 | en_US |
| dc.identifier.wos | 000601273000001 | en_US |
| dc.language.iso | eng | en_US |
| dc.relation.isversionof | 10.3389/fonc.2020.619709 | en_US |
| dc.relation.journal | FRONTIERS IN ONCOLOGY | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | cutaneous B-cell lymphoma | en_US |
| dc.subject | skin cancer | en_US |
| dc.subject | B-cell | en_US |
| dc.subject | immunotherapy | en_US |
| dc.subject | immunosuppression | en_US |
| dc.title | Editorial: Cutaneous B-Cell Lymphomas | en_US |
| dc.type | editorial | en_US |